JYOTHYLABNSEJyothy Labs Limited· Personal CareMediumNeutral
Announced Mon, 22 Jun · 15:05 IST

Jyothy Labs: Henkel ends Pril and Fa licenses, company begins arbitration

Mgmt Guided Margin PressureMgmt Evaded Key QuestionInvestor Communications View source PDF

JYOTHYLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹202.99
prior close
₹204.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.0+0.1-0.4-1.5-1.0-3.6-5.5-4.3-1.4-1.0
Up moveDown movePending
AI summary

Henkel will not renew Jyothy Labs' licenses for Pril and Fa brands after May 31, 2026. The company stopped manufacturing and selling these brands from June 1, 2026. Pril contributed 7 to 8 percent of revenue, roughly Rs 225 to 240 crore. Fa's contribution was limited. Jyothy Labs has filed for arbitration at the Singapore International Arbitration Center to protect contractual rights on exit terms and consideration. Management expects near-term margin softness in FY27 as a transition year. Exo Dishwash Liquid will be scaled up to fill the gap, with new product launches planned across categories. Inorganic growth options are also being evaluated.

Likely market impact

Near-term revenue and margin pressure from losing Pril; long-term depends on Exo scaling, new launches, and arbitration outcome.